APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lanreotide Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lanreotide Injection Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchLanreotide Injection Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Lanreotide Injection Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Lanreotide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lanreotide Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Lanreotide Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lanreotide Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lanreotide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lanreotide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lanreotide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lanreotide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lanreotide Injection include Ipsen and Cipla etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lanreotide Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lanreotide Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Lanreotide Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lanreotide Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lanreotide Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lanreotide Injection sales, projected growth trends, production technology, application and end-user industry.

Lanreotide Injection Segment by Company

Ipsen

Cipla

Lanreotide Injection Segment by Type

Sustained Release Formulation

Long-acting Formula

Lanreotide Injection Segment by Application

Hospital

Clinic

Others

Lanreotide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lanreotide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lanreotide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lanreotide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lanreotide Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lanreotide Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lanreotide Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lanreotide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sustained Release Formulation Major Manufacturers Table 3. Long-acting Formula Major Manufacturers Table 4. Global Lanreotide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Lanreotide Injection Industry Trends Table 9. Lanreotide Injection Industry Drivers Table 10. Lanreotide Injection Industry Opportunities and Challenges Table 11. Lanreotide Injection Industry Restraints Table 12. Global Lanreotide Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Lanreotide Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Lanreotide Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Lanreotide Injection Revenue Market Share by Region (2021-2026) Table 16. Global Lanreotide Injection Revenue Market Share by Region (2027-2032) Table 17. Global Lanreotide Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Lanreotide Injection Sales by Region (2021-2026) & (k units) Table 19. Global Lanreotide Injection Sales by Region (2027-2032) & (k units) Table 20. Global Lanreotide Injection Sales Market Share by Region (2021-2026) Table 21. Global Lanreotide Injection Sales Market Share by Region (2027-2032) Table 22. Global Lanreotide Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Lanreotide Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Lanreotide Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lanreotide Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Lanreotide Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Lanreotide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Lanreotide Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Lanreotide Injection Manufacturers, Product Type & Application Table 30. Global Lanreotide Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Lanreotide Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Lanreotide Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Lanreotide Injection Revenue Market Share by Type (2021-2026) Table 37. Global Lanreotide Injection Revenue Market Share by Type (2027-2032) Table 38. Global Lanreotide Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 40. Global Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 41. Global Lanreotide Injection Sales Market Share by Type (2021-2026) Table 42. Global Lanreotide Injection Sales Market Share by Type (2027-2032) Table 43. Global Lanreotide Injection Price by Type (2021-2026) & (US$/unit) Table 44. Global Lanreotide Injection Price by Type (2027-2032) & (US$/unit) Table 45. Global Lanreotide Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Lanreotide Injection Revenue Market Share by Application (2021-2026) Table 49. Global Lanreotide Injection Revenue Market Share by Application (2027-2032) Table 50. Global Lanreotide Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 52. Global Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 53. Global Lanreotide Injection Sales Market Share by Application (2021-2026) Table 54. Global Lanreotide Injection Sales Market Share by Application (2027-2032) Table 55. Global Lanreotide Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Lanreotide Injection Price by Application (2027-2032) & (US$/unit) Table 57. Ipsen Company Information Table 58. Ipsen Business Overview Table 59. Ipsen Lanreotide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Ipsen Lanreotide Injection Product Portfolio Table 61. Ipsen Recent Development Table 62. Cipla Company Information Table 63. Cipla Business Overview Table 64. Cipla Lanreotide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Cipla Lanreotide Injection Product Portfolio Table 66. Cipla Recent Development Table 67. North America Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 70. North America Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 71. North America Lanreotide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 72. North America Lanreotide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 73. North America Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 76. North America Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 77. North America Lanreotide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 78. North America Lanreotide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 79. North America Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Lanreotide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Lanreotide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 83. North America Lanreotide Injection Sales by Country (2021-2026) & (k units) Table 84. North America Lanreotide Injection Sales by Country (2027-2032) & (k units) Table 85. North America Lanreotide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 86. North America Lanreotide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 87. United States Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 88. Canada Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 89. Mexico Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 90. Europe Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 93. Europe Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 94. Europe Lanreotide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 95. Europe Lanreotide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 96. Europe Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 99. Europe Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 100. Europe Lanreotide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 101. Europe Lanreotide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 102. Europe Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Lanreotide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Lanreotide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. Europe Lanreotide Injection Sales by Country (2021-2026) & (k units) Table 107. Europe Lanreotide Injection Sales by Country (2027-2032) & (k units) Table 108. Europe Lanreotide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 109. Europe Lanreotide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 110. Germany Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 111. France Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 112. U.K. Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 113. Italy Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 114. Russia Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 115. Spain Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 118. Sweden Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 119. Poland Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 120. China Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 121. China Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 122. China Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 123. China Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 124. China Lanreotide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 125. China Lanreotide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 126. China Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 127. China Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 128. China Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 129. China Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 130. China Lanreotide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 131. China Lanreotide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 132. Asia Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 135. Asia Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 136. Asia Lanreotide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 137. Asia Lanreotide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 138. Asia Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 141. Asia Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 142. Asia Lanreotide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 143. Asia Lanreotide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 144. Asia Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Lanreotide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Lanreotide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Asia Lanreotide Injection Sales by Country (2021-2026) & (k units) Table 149. Asia Lanreotide Injection Sales by Country (2027-2032) & (k units) Table 150. Asia Lanreotide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 151. Asia Lanreotide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 152. Japan Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 153. South Korea Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 154. India Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 155. Australia Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Lanreotide Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Lanreotide Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Lanreotide Injection Sales by Type (2021-2026) & (k units) Table 161. SAMEA Lanreotide Injection Sales by Type (2027-2032) & (k units) Table 162. SAMEA Lanreotide Injection Sales Price by Type (2021-2026) & (US$/unit) Table 163. SAMEA Lanreotide Injection Sales Price by Type (2027-2032) & (US$/unit) Table 164. SAMEA Lanreotide Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Lanreotide Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Lanreotide Injection Sales by Application (2021-2026) & (k units) Table 167. SAMEA Lanreotide Injection Sales by Application (2027-2032) & (k units) Table 168. SAMEA Lanreotide Injection Sales Price by Application (2021-2026) & (US$/unit) Table 169. SAMEA Lanreotide Injection Sales Price by Application (2027-2032) & (US$/unit) Table 170. SAMEA Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Lanreotide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Lanreotide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. SAMEA Lanreotide Injection Sales by Country (2021-2026) & (k units) Table 175. SAMEA Lanreotide Injection Sales by Country (2027-2032) & (k units) Table 176. SAMEA Lanreotide Injection Sales Price by Country (2021-2026) & (US$/unit) Table 177. SAMEA Lanreotide Injection Sales Price by Country (2027-2032) & (US$/unit) Table 178. Brazil Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 179. Argentina Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 180. Chile Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 181. Colombia Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 182. Peru Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 184. Israel Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 185. UAE Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 186. Turkey Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 187. Iran Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 188. Egypt Lanreotide Injection Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Lanreotide Injection Distributors List Table 192. Lanreotide Injection Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Lanreotide Injection Image Figure 2. Global Lanreotide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lanreotide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sustained Release Formulation Image Figure 5. Long-acting Formula Image Figure 6. Global Lanreotide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lanreotide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Lanreotide Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lanreotide Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Lanreotide Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Lanreotide Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Lanreotide Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Lanreotide Injection Sales (2021-2032) & (k units) Figure 17. Global Lanreotide Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Lanreotide Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Lanreotide Injection Sales YoY (2021-2032) & (k units) Figure 20. Europe Lanreotide Injection Sales YoY (2021-2032) & (k units) Figure 21. China Lanreotide Injection Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Lanreotide Injection Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Lanreotide Injection Sales YoY (2021-2032) & (k units) Figure 24. Global Lanreotide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Lanreotide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Lanreotide Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Lanreotide Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Lanreotide Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Lanreotide Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Lanreotide Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lanreotide Injection Sales Market Share by Type (2021-2032) Figure 33. Global Lanreotide Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Lanreotide Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Lanreotide Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Lanreotide Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Lanreotide Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lanreotide Injection Sales Market Share by Application (2021-2032) Figure 39. North America Lanreotide Injection Revenue Share by Type (2021-2032) Figure 40. North America Lanreotide Injection Sales Share by Type (2021-2032) Figure 41. North America Lanreotide Injection Revenue Share by Application (2021-2032) Figure 42. North America Lanreotide Injection Sales Share by Application (2021-2032) Figure 43. North America Lanreotide Injection Revenue Share by Country (2021-2032) Figure 44. North America Lanreotide Injection Sales Share by Country (2021-2032) Figure 45. Europe Lanreotide Injection Revenue Share by Type (2021-2032) Figure 46. Europe Lanreotide Injection Sales Share by Type (2021-2032) Figure 47. Europe Lanreotide Injection Revenue Share by Application (2021-2032) Figure 48. Europe Lanreotide Injection Sales Share by Application (2021-2032) Figure 49. Europe Lanreotide Injection Revenue Share by Country (2021-2032) Figure 50. Europe Lanreotide Injection Sales Share by Country (2021-2032) Figure 51. China Lanreotide Injection Revenue Share by Type (2021-2032) Figure 52. China Lanreotide Injection Sales Share by Type (2021-2032) Figure 53. China Lanreotide Injection Revenue Share by Application (2021-2032) Figure 54. China Lanreotide Injection Sales Share by Application (2021-2032) Figure 55. Asia Lanreotide Injection Revenue Share by Type (2021-2032) Figure 56. Asia Lanreotide Injection Sales Share by Type (2021-2032) Figure 57. Asia Lanreotide Injection Revenue Share by Application (2021-2032) Figure 58. Asia Lanreotide Injection Sales Share by Application (2021-2032) Figure 59. Asia Lanreotide Injection Revenue Share by Country (2021-2032) Figure 60. Asia Lanreotide Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Lanreotide Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Lanreotide Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Lanreotide Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Lanreotide Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Lanreotide Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Lanreotide Injection Sales Share by Country (2021-2032) Figure 67. Lanreotide Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Lanreotide Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sustained Release Formulation
  • Long-acting Formula
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Ipsen
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lanreotide Injection Market by Type
  3. 1.2.1 Global Lanreotide Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sustained Release Formulation
  5. 1.2.3 Long-acting Formula
  6. 1.3 Lanreotide Injection Market by Application
  7. 1.3.1 Global Lanreotide Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lanreotide Injection Market Dynamics
  1. 2.1 Lanreotide Injection Industry Trends
  2. 2.2 Lanreotide Injection Industry Drivers
  3. 2.3 Lanreotide Injection Industry Opportunities and Challenges
  4. 2.4 Lanreotide Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lanreotide Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lanreotide Injection Revenue by Region
  3. 3.2.1 Global Lanreotide Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lanreotide Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Lanreotide Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Lanreotide Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lanreotide Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lanreotide Injection Sales by Region
  9. 3.4.1 Global Lanreotide Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lanreotide Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Lanreotide Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Lanreotide Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lanreotide Injection Revenue by Manufacturers
  2. 4.1.1 Global Lanreotide Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lanreotide Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lanreotide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lanreotide Injection Sales by Manufacturers
  6. 4.2.1 Global Lanreotide Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lanreotide Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lanreotide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lanreotide Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lanreotide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lanreotide Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lanreotide Injection Manufacturers, Product Type & Application
  13. 4.7 Global Lanreotide Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lanreotide Injection Market CR5 and HHI
  16. 4.8.2 2025 Lanreotide Injection Tier 1, Tier 2, and Tier 3
5 Lanreotide Injection Market by Type
  1. 5.1 Global Lanreotide Injection Revenue by Type
  2. 5.1.1 Global Lanreotide Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lanreotide Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lanreotide Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lanreotide Injection Sales by Type
  6. 5.2.1 Global Lanreotide Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lanreotide Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Lanreotide Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lanreotide Injection Price by Type
6 Lanreotide Injection Market by Application
  1. 6.1 Global Lanreotide Injection Revenue by Application
  2. 6.1.1 Global Lanreotide Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lanreotide Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lanreotide Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lanreotide Injection Sales by Application
  6. 6.2.1 Global Lanreotide Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lanreotide Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Lanreotide Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lanreotide Injection Price by Application
7 Company Profiles
  1. 7.1 Ipsen
  2. 7.1.1 Ipsen Company Information
  3. 7.1.2 Ipsen Business Overview
  4. 7.1.3 Ipsen Lanreotide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ipsen Lanreotide Injection Product Portfolio
  6. 7.1.5 Ipsen Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Lanreotide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Lanreotide Injection Product Portfolio
  12. 7.2.5 Cipla Recent Developments
8 North America
  1. 8.1 North America Lanreotide Injection Market Size by Type
  2. 8.1.1 North America Lanreotide Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Lanreotide Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Lanreotide Injection Price by Type (2021-2032)
  5. 8.2 North America Lanreotide Injection Market Size by Application
  6. 8.2.1 North America Lanreotide Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Lanreotide Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Lanreotide Injection Price by Application (2021-2032)
  9. 8.3 North America Lanreotide Injection Market Size by Country
  10. 8.3.1 North America Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lanreotide Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lanreotide Injection Market Size by Type
  2. 9.1.1 Europe Lanreotide Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lanreotide Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Lanreotide Injection Price by Type (2021-2032)
  5. 9.2 Europe Lanreotide Injection Market Size by Application
  6. 9.2.1 Europe Lanreotide Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lanreotide Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Lanreotide Injection Price by Application (2021-2032)
  9. 9.3 Europe Lanreotide Injection Market Size by Country
  10. 9.3.1 Europe Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lanreotide Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lanreotide Injection Market Size by Type
  2. 10.1.1 China Lanreotide Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Lanreotide Injection Sales by Type (2021-2032)
  4. 10.1.3 China Lanreotide Injection Price by Type (2021-2032)
  5. 10.2 China Lanreotide Injection Market Size by Application
  6. 10.2.1 China Lanreotide Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Lanreotide Injection Sales by Application (2021-2032)
  8. 10.2.3 China Lanreotide Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lanreotide Injection Market Size by Type
  2. 11.1.1 Asia Lanreotide Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lanreotide Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Lanreotide Injection Price by Type (2021-2032)
  5. 11.2 Asia Lanreotide Injection Market Size by Application
  6. 11.2.1 Asia Lanreotide Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lanreotide Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Lanreotide Injection Price by Application (2021-2032)
  9. 11.3 Asia Lanreotide Injection Market Size by Country
  10. 11.3.1 Asia Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lanreotide Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lanreotide Injection Market Size by Type
  2. 12.1.1 SAMEA Lanreotide Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lanreotide Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lanreotide Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Lanreotide Injection Market Size by Application
  6. 12.2.1 SAMEA Lanreotide Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lanreotide Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lanreotide Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Lanreotide Injection Market Size by Country
  10. 12.3.1 SAMEA Lanreotide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lanreotide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lanreotide Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lanreotide Injection Value Chain Analysis
  2. 13.1.1 Lanreotide Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lanreotide Injection Production Mode & Process
  6. 13.2 Lanreotide Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lanreotide Injection Distributors
  9. 13.2.3 Lanreotide Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst